In addition to colon cancer-associated mutations, PPARγ R280C and R288C found in uterine and skin cancers reduced the transcriptional activity of PPARγ and resulted in remarkably weak binding affinities for RXRα and MED1 co-activators (Figure 3 and Figure 4). Here, PPARG is linked to malignant colon neoplasm.